コンテンツへスキップ
Merck

RECYMAG65K27PMX

MILLIPLEX®マウスサイトカイン／ケモカイン磁気ビーズパネル - プレミックス27プレックス - 免疫学マルチプレックスアッセイ

Premixed Rat Cytokine/Chemokine 27-Plex Panel

別名:

rat cytokine assay, rat cytokine multiplex panel, rat growth factor panel, rat inflammation biomarker panel, rodent cytokine analysis kit

ログインで組織・契約価格をご覧ください。

サイズを選択してください

この商品について

UNSPSC Code:
12161503
NACRES:
NA.47
eCl@ss:
32161000

主要文書

すべての文書を表示
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします

species reactivity

rat

Quality Level

200

assay range

accuracy: 80-131%, standard curve range: 0.2-1,000 pg/mL
(EGF), standard curve range: 1.2-5,000 pg/mL
(GRO/KC), standard curve range: 12.2-50,000 pg/mL
(GM-CSF, IL-1α, IL-2, IL-12 (p70), IL-18), standard curve range: 14.6-60,000 pg/mL
(IFNγ, MIP-1α), standard curve range: 2.4-10,000 pg/mL
(Fractalkine, IP-10, Leptin, TNFα), standard curve range: 24.4-100,000 pg/mL
(LIX, MIP-2), standard curve range: 4.9-20,000 pg/mL
(Eotaxin, C-CSF, IL-4, IL-5, IL-13, RANTES, VEGF), standard curve range: 7.3-30,000 pg/mL
(IL-10, IL-17A, MCP-1), standard curve range: 73.2-300,000 pg/mL
(IL-6)

technique(s)

multiplexing: suitable

input

cell culture supernatant(s)
tissue/cellular lysate

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

類似した製品をお探しですか？ 訪問 製品比較ガイド

関連するカテゴリー

General description

Rat cytokines and chemokines are critical signaling molecules that orchestrate immune responses, inflammation, and cellular communication in rodent models, making them essential biomarkers for preclinical research in drug development, toxicology studies, and disease pathogenesis. These small proteins, including interleukins, tumor necrosis factors, interferons, and chemotactic factors, regulate diverse physiological processes from wound healing and infection response to cancer progression and autoimmune disorders.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze 27 analytes in rat serum, plasma, tissue/cell lysates, and cell culture supernatants.

Analytes included: EGF, Eotaxin/CCL11, Fractalkine, G-CSF, GM-CSF, GRO/KC, IFN-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, IL-17A, IL-18, IP-10, Leptin, LIX, MCP-1, MIP-1α, MIP-2, RANTES, TNF-α, VEGF

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

Unmatched Breadth: Enables comprehensive immune profiling in rat models—ideal for inflammation, immunology, and disease research.

Sample Efficiency: Requires only 25 µL per well, conserving precious samples.

Time-Saving Workflow: Complete assay in one day, streamlining lab operations.

Robust Data Quality: Fluorometric detection ensures quantitative, reproducible results.

Trusted Brand: Backed by our rigorous quality control and scientific support.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

保管分類

10 - Combustible liquids

wgk

WGK 3

適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

キットコンポーネントの情報を参照してください

pdsc

キットコンポーネントの情報を参照してください

prtr

キットコンポーネントの情報を参照してください

fsl

キットコンポーネントの情報を参照してください

ishl_indicated

キットコンポーネントの情報を参照してください

ishl_notified

キットコンポーネントの情報を参照してください

cart

キットコンポーネントの情報を参照してください

jan

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Bin Cai et al.
BioMed research international, 2016, 1469590-1469590 (2016-05-20)
Citrulline (Cit) supplementation was proposed to serve as a therapeutic intervention to restore arginine (Arg) concentrations and improve related functions in sepsis. This study explored whether citrulline had positive effects on liver injury and cytokine release in the early stages
Dominic Friston et al.
Disease models & mechanisms, 13(4) (2020-03-05)
Burn injury is a pathology underpinned by progressive and aberrant inflammation. It is a major clinical challenge to survival and quality of life. Although the complex local and disseminating pathological processes of a burn injury ultimately stem from local tissue
Ahsia M Clayton et al.
Brain, behavior, and immunity, 70, 376-389 (2018-03-29)
Reduced placental blood flow results in placental ischemia, an initiating event in the pathophysiology of preeclampsia, a hypertensive pregnancy disorder. While studies show increased mortality risk from Alzheimer's disease, stroke, and cerebrovascular complications in women with a history of preeclampsia
Norhashima Abd Rashid et al.
EXCLI journal, 19, 1246-1265 (2020-10-31)
Oxidative stress, inflammation and apoptosis are thought as primary mediators of cisplatin-induced hepatotoxicity. The objective of this study was to determine the protective effect of Polygonum minus essential oil in cisplatin-induced hepatotoxicity. A total of forty-two male rats were randomly
Jonathan D Finn et al.
Cell reports, 22(9), 2227-2235 (2018-03-01)
The development of clinically viable delivery methods presents one of the greatest challenges in the therapeutic application of CRISPR/Cas9 mediated genome editing. Here, we report the development of a lipid nanoparticle (LNP)-mediated delivery system that, with a single administration, enabled
関連する文献をすべて表示

グローバルトレードアイテム番号

カタログ番号GTIN
RECYMAG65K27PMX04055977289145

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら（テクニカルサービス）